Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by quietobserveron Jun 03, 2019 3:11pm

164 Views

Post# 29794883

RE:RE:RE:updates from Joel @ IR

He did kind of clarify "Simon maintained his optimism that the company will generate $500 million in revenue this calendar year and $1 billion by the end of 2020 during a conference call with analysts earlier on Monday.

jayjay2020 wrote:

MomentumMan wrote: **Note Q1 2020 started on June 1, 2019

Our fiscal year is somewhat of a mind fu*k. Most people thinking next year meanwhile we are on the verge...

momo

jayjay2020 wrote:

"Regarding the Extraction Centre of Excellence, we would like to clarify that there is no updated announcement with regards to its status. The Centre is on schedule to be completed in (fiscal) Q1 2020. The targeted completion date has not changed from previous public disclosures.

Please note that the Health Canada license application for the Centre is an amendment to an existing license and not a 2nd site license. The expected timing of the licensing approval from Health Canada is unknown."

Thanks,

Joel Pierce Investor Relations Administrator Joel.Pierce@aphria.com | www.aphria.ca Twitter | LinkedIn

**Note Q1 2020 started on June 1, 2019

yes it is ... Irwin needs to clarify his comment about $1B revs. in 2020. Is it FYE 2020 or is calendar year 2020?